GenSensor

Founded in 2016 and based in Paris, GenSensor operates at the intersection of diagnostics and digital health, focusing on bioprocess optimization. Its core offering is a hybrid platform featuring a unique bench robot for automated sampling and preparation, coupled with AI-driven analytical software that provides insights into cell behavior and process performance. The company serves a broad industrial base by enabling data-driven process development, scale-up, and troubleshooting, positioning itself as a key enabler for Quality by Design (QbD) and digitalization in biologics manufacturing.

Integrated platform combining a unique bench robot for automated, aseptic bioprocess sampling and sample preparation with AI-powered analytical software that monitors biomarkers and cell signaling pathways to optimize upstream bioprocesses.

GenSensor competes with large, diversified life science tools companies (e.g., Sartorius, Thermo Fisher, Danaher) that offer bioreactors, sensors, and analytics software, as well as with smaller startups focused on specific Process Analytical Technology (PAT) solutions. Its differentiation lies in the integrated hardware-AI system specifically designed for biomarker-driven process understanding.